Ennigerloh & Rostock, May 5th, 2020 – SensID GmbH is a leading specialist in quality diagnostics and offers a SARS-CoV-2 immunity testing service to all interested companies (and their staff) as part of an initiative of the State of Mecklenburg-Western Pomerania (to cope with the economic consequences of the pandemic).
Rottendorf Pharma, with its headquarters in Ennigerloh, Germany, and with more than 1100 employees, is one of the leading contract development and manufacturing organizations (CDMO) for solid dosage forms for the international pharmaceutical industry.
“The approach and the competence of SensID immediately convinced us to offer all of our employees voluntary immunity testing. As a relevant and internationally important service provider in the pharmaceutical manufacturing and development area (CDMO), it is crucial that we ensure our long-term delivery capability in the current Corona crisis. The consequent testing of our employees on an already existing immunity will be a targeted supportive measure here!” emphasizes Dr. Silke Huster, Executive Officer of Rottendorf Pharma GmbH.
Björn Nowack, CEO and co-founder of SensID adds: “The future cooperation with Rottendorf Pharma underlines our clear position within the area of quality diagnostics and our capability to react very quickly and flexibly to market needs in the interest of our customers.”
About SensID – Bringing Precision to MDx
Sens-ID, headquartered in Rostock, Germany, is specialized in the development, manufacturing and marketing of reference materials and quality controls for molecular, DNA based diagnostics. We offer to our customers reference materials and quality controls precisely characterized and manufactured in compliance with the highest standards. Our continuously growing product portfolio offers ideal solution options for your R&D programs as well as assay and instrument validation requirements. They can serve as external controls, support accreditation, ring trials, conformity assessment, and should be a part of your diagnostic kits.
For more information, please visit www.sens-id.com
18057 Rostock, Germany
T+49 381 37718201
About Rottendorf Pharma
Rottendorf Pharma GmbH, with headquarters in Germany and a subsidiary in the USA, is a leading contract development and manufacturing organization (CDMO) for solid dosage forms. For more than 90 years, the company has been producing, packing, analyzing and developing solid dosage forms. The company, with its 1100 employees and a turnover of more than 160 million €, sees itself as a modern service provider with a strong transatlantic focus. With its four unique selling points – the unique company structure that stands for sustainability, the innovative service concept “Total Process Ownership” (TPO) that stands for an exceptional level of service, the “Total Technological Mastering” (TTM) that stands for first-class pharmaceutical competence, and the very good on time delivery – Rottendorf significantly distinguishes itself from its competitors.
Gema Moreno Cobo
Rottendorf Pharma GmbH
Ostenfelder Str. 51-61
59320 Ennigerloh, Germany
Tel. +49 2524 268226